Abbott Laboratories Shs Cert Deposito Arg Repr 0.25 ShsAbbott Laboratories Shs Cert Deposito Arg Repr 0.25 ShsAbbott Laboratories Shs Cert Deposito Arg Repr 0.25 Shs

Abbott Laboratories Shs Cert Deposito Arg Repr 0.25 Shs

No trades
No trades

Key facts today


Abbott Laboratories (ABT) posted strong quarterly margins and nutrition-segment growth, plans new nutrition products for GLP-1 users, and has upcoming heart‑device and diabetes‑monitoring launches. 1
Analyze the impactAnalyze the impact
Market capitalization
‪175.49 B‬USD
‪5.58 B‬USD
‪38.04 B‬USD
Beta (1Y)
−0.01

Details


CEO
Robert B. Ford
Website
Headquarters
Abbott Park
Founded
1888
IPO date
Mar 1, 1937
ISIN
ARDEUT110608
FIGI
BBG000HDMQX4
Identifiers
ISIN ARDEUT110608
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment focuses on branded generic pharmaceuticals that are manufactured worldwide and marketed and sold outside the United States, primarily in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternative care testing sites. The Nutritional Products segment oversees the worldwide sale of pediatric and adult nutritional products. The Medical Devices segment offers a broad range of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, as well as diabetes care and continuous glucose monitoring products. It also provides neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
6.675% YTM
Maturity dateApr 15, 2043
Coupon4.75% (Fixed)
6.023% YTM
Maturity dateMar 15, 2066
Coupon5.60% (Fixed)
5.946% YTM
Maturity dateMar 15, 2056
Coupon5.50% (Fixed)
5.877% YTM
Maturity dateNov 30, 2046
Coupon4.90% (Fixed)
5.793% YTM
Maturity dateApr 15, 2043
Coupon4.75% (Fixed)
5.511% YTM
Maturity dateMay 27, 2040
Coupon5.30% (Fixed)
5.482% YTM
Maturity dateApr 1, 2039
Coupon6.00% (Fixed)
5.440% YTM
Maturity dateMar 15, 2038
Coupon4.75% (Fixed)
5.347% YTM
Maturity dateNov 30, 2037
Coupon6.15% (Fixed)
5.343% YTM
Maturity dateNov 30, 2036
Coupon4.75% (Fixed)
5.314% YTM
Maturity dateMar 15, 2036
Coupon4.65% (Fixed)

See all ABTD bonds